Correction to: Nature Biotechnology https://doi.org/10.1038/s41587-023-01796-7. Published online 25 May 2023.
In the version of this article initially published, in Figure 4c, the image for the PAPVB16−ICI group at timepoint day 30 was mistakenly duplicated for the same group at days 40, 50 and 60. In addition, during the generation of higher-resolution figures for the Supplementary Information, typographical errors occurred, causing details such as labels and titles to be omitted from graphs, as well as some inadvertent image duplications. A revised Supplementary Information file with the corrected figures has now been uploaded online. For transparency, changes to the Supplementary Figures and to Figure 4c are outlined in the Supplementary Information attached to this notice. The errors have been corrected in the HTML and PDF versions of the article.
Supplementary Information is available in the online version of this notice.
Author information
Authors and Affiliations
Corresponding authors
Supplementary information
Supplementary Information
Supplementary Information
Rights and permissions
About this article
Cite this article
Ji, D., Zhang, Y., Sun, J. et al. Author Correction: An engineered influenza virus to deliver antigens for lung cancer vaccination. Nat Biotechnol 42, 529 (2024). https://doi.org/10.1038/s41587-023-01884-8
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41587-023-01884-8
